Factores relacionados con histoplasmosis diseminada en los pacientes admitidos con VIH-SIDA y fiebre, CHDrAAM, 2017 - 2019
[Factors related to disseminated histoplasmosis in patients admitted with HIV-AIDS and fever: CHDrAAM, 2017 - 2019]José Anel González Rodriguéz1, Elam Chérigo1, Nathan Gundacker2, José Antonio Suárez3
1. Departamento de Infectología, Complejo Hospitalario Dr Arnulfo Arias Madrid Panamá, Panamá; 2. División de Enfermedades Infecciosas, Medical College of Wisconsin, USA; 3. Instituto Conmemorativo Gorgas de Estudios de la Salud, SNI Senacyt Panamá;
Descargas
Resumen
Introducción: el diagnóstico de histoplasmosis diseminada (HD) es un desafío debido a la similitud del cuadro clínico con otras enfermedades infecciosas y no infecciosas. Confirmar un caso de HD requiere realizar procedimientos poco sensibles como hemocultivos, mielocultivos y biopsias de tejidos, o costosos como el antígeno urinario de Histoplasma capsulatum. Conocer los factores clínicos y de laboratorios relacionados con el diagnóstico de HD es de vital importancia en especial en sitios con recursos limitados. Metodología: se realizó un estudio de cohorte retrospectivo donde los expedientes clínicos de los pacientes con fiebre y VIH-SIDA, admitidos con sospecha de histoplasmosis diseminada del 1 de enero de 2017 al 31 de diciembre de 2019 en el Complejo Hospitalario Dr. Arnulfo Arias Madrid (CHDrAAM) de Panamá, fueron evaluados por características demográficas, clínicas y de laboratorio relacionadas con el diagnóstico de HD. Resultados: 63 pacientes cumplieron los criterios de inclusión, 14 con diagnóstico confirmado de HD y 49 con diagnóstico no confirmado de HD. Los niveles de lactato deshidrogenasa (LDH) y aspartato transaminasa (AST) se relacionaron con el diagnóstico de HD en el análisis univariado. Luego de realizar regresión logística ni AST ni LDH fueron estadísticamente significativas. (p= 0.22 y P = 0.92). Conclusión: Ninguna característica clínica ni de laboratorio se relacionó de forma independiente con el diagnóstico de HD, en pacientes con VIH-SIDA admitidos con sospecha de histoplasmosis diseminada.
Abstract
Introduction: The diagnosis of disseminated histoplasmosis (HD) is a challenge due to the similarity of the clinical picture with other infectious and non-infectious diseases. Confirming a case of HD requires performing insensitive procedures such as blood cultures, myelocultures and tissue biopsies, or expensive procedures such as urinary Histoplasma capsulatum antigen. Knowing the clinical and laboratory factors related to the diagnosis of HD is of vital importance, especially in places with limited resources. Methodology: a retrospective cohort study was conducted where clinical records of patients with fever and HIV-AIDS, admitted with suspected disseminated histoplasmosis from January 1, 2017, to December 31, 2019, at the Complejo Hospitalario Dr. Arnulfo Arias Madrid (CHDrAAM) in Panama, were evaluated for demographic, clinical and laboratory characteristics related to the diagnosis of HD. Results: 63 patients met the inclusion criteria, 14 with confirmed diagnosis of HD and 49 with unconfirmed diagnosis of HD. Lactate dehydrogenase (LDH) and aspartate transaminase (AST) levels were related to HD diagnosis in univariate analysis. After logistic regression neither AST nor LDH were statistically significant. (p= 0.22 and P = 0.92). Conclusion: No clinical or laboratory characteristics were independently related to the diagnosis of HD in HIV-AIDS patients admitted with suspected disseminated histoplasmosis.
Citas
[1] Sahaza JH. et al. Thermotolerance of Histoplasma capsulatum at 40 °C predominates among clinical isolates from different Latin American regions. Brazilian J Infect Dis. 2020;24(1):44-50. DOI: https://doi.org/10.1016/j.bjid.2019.12.007
[2] Kauffman CA. Histoplasmosis. Clin Chest Med. 2009;30(2):217-225. DOI: https://doi.org/10.1016/j.ccm.2009.02.002
[3] Wheat LJ. et al. Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45(7):807-825. DOI: https://doi.org/10.1086/521259
[4] Adenis AA. et al. Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study. Lancet Infect Dis. 2018;18(10):1150-1159. DOI: https://doi.org/10.1016/S1473-3099(18)30354-2
[5] Gutierrez ME. Canton A, Sosa N, Puga E, Talavera L. Disseminated Histoplasmosis in Patients with AIDS in Panama: A Review of 104 Cases. Clin Infect Dis. 2005;40(8):1199-1202. doi:10.1086/428842 DOI: https://doi.org/10.1086/428842
[6] Milagros Beitia Ureña, Edgar Rodriguez, Ana Belén Araúz Rodríguez, Disseminated histoplasmosis in Patients With AIDS: Five-Year Clinical Experience in a Tertiary Care Teaching Hospital of Panama, Open Forum Infectious Diseases, Volume 2, Issue suppl_1, December 2015, 1692 DOI: https://doi.org/10.1093/ofid/ofv133.1243
[7] Darling, Samuel. Histoplasmosis: a fatal infectious disease resembling kala-azar found among natives of tropical America. arch intern med (chic). 1908; ii (2):107-123. DOI: https://doi.org/10.1001/archinte.1908.00050070002001
[8] Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet. 2018;392(10151):951-970 DOI: https://doi.org/10.1016/S0140-6736(18)31204-2
[9] Wang JY, Hsueh PR, Wang SK, Jan IS, Lee LN, Liaw YS, Yang PC, Luh KT. Disseminated tuberculosis: a 10-year experience in a medical center. Medicine (Baltimore). 2007 Jan; 86(1):39-46. DOI: https://doi.org/10.1097/MD.0b013e318030b605
[10] Graviss EA. et al. Clinical prediction model for differentiation of disseminated Histoplasma capsulatum and Mycobacterium avium complex infections in febrile patients with AIDS. J Acquir Immune Deficiency Syndrome. 2000; 24(1):30‐36. DOI: https://doi.org/10.1097/00042560-200005010-00005
[11] Corcoran GR. et al. Markedly elevated serum lactate dehydrogenase levels are a clue to the diagnosis of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis. 1997;24(5):942-944. DOI: https://doi.org/10.1093/clinids/24.5.942
[12] Couppie P, Sobesky M, Aznar C, et al. Histoplasmosis and Acquired Immunodeficiency Syndrome: A Study of Prognostic Factors. Clin Infect Dis. 2004;38(1):134-138. doi:10.1086/379770 DOI: https://doi.org/10.1086/379770
[13] Center for Disease Control and Prevention. Surveillance case definition of Histoplasmosis. https://wwwn.cdc.gov/nndss/conditions/histoplasmosis/case-definition/2017.
[14] Leedy N, Cari EV, Wheat LJ. HIV-Associated Histoplasmosis : Current Perspectives. 2020:113-125. DOI: https://doi.org/10.2147/HIV.S185631
[15] Couppie P, Sobesky M, Aznar C, et al. Histoplasmosis and Acquired Immunodeficiency Syndrome: A Study of Prognostic Factors. Clin Infect Dis. 2004;38(1):134-138. DOI: https://doi.org/10.1086/379770
[16] White PL, Backx M, Barnes RA. Diagnosis and management of Pneumocystis jirovecii infection. Expert Rev Anti Infect Ther. 2017 May; 15(5):435-447. DOI: https://doi.org/10.1080/14787210.2017.1305887
[17] Tasaka S, Hasegawa N, Kobayashi S, Yamada W, Nishimura T, Takeuchi T, Ishizaka A. Serum indicators for the diagnosis of pneumocystis pneumonia. Chest. 2007 Apr; 131(4):1173-80. DOI: https://doi.org/10.1378/chest.06-1467
[18] Schmidt, J.J., Lueck, C., Ziesing, S. et al. Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years. Crit Care 22, 307 (2018). DOI: https://doi.org/10.1186/s13054-018-2221-8
[19] Quist J, Hill AR. Serum lactate dehydrogenase (LDH) in Pneumocystis carinii pneumonia, tuberculosis, and bacterial pneumonia. Chest. 1995 Aug; 108(2):415-8. DOI: https://doi.org/10.1378/chest.108.2.415
[20] Ramos IC, Soares YC, Damasceno LS, et al. Predictive factors for disseminated histoplasmosis in AIDS patients with fever admitted to a reference hospital in Brazil. Rev Soc Bras Med Trop. 2018;51(4):479-484. DOI: https://doi.org/10.1590/0037-8682-0425-2017
Licencia
Derechos de autor 2021 Infomedic Intl.Derechos autoriales y de reproducibilidad. La Revista Médica de Panama es un ente académico, sin fines de lucro, que forma parte de la Academia Panameña de Medicina y Cirugía. Sus publicaciones son de tipo acceso gratuito de su contenido para uso individual y académico, sin restricción. Los derechos autoriales de cada artículo son retenidos por sus autores. Al Publicar en la Revista, el autor otorga Licencia permanente, exclusiva, e irrevocable a la Sociedad para la edición del manuscrito, y otorga a la empresa editorial, Infomedic International Licencia de uso de distribución, indexación y comercial exclusiva, permanente e irrevocable de su contenido y para la generación de productos y servicios derivados del mismo. En caso que el autor obtenga la licencia CC BY, el artículo y sus derivados son de libre acceso y distribución.
